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VaccineThe World Health Organization’s Regional Offices for Africa and for the Eastern Mediterranean in con-
junction with the African Union and the Government of Ethiopia hosted a ministerial conference on
immunization in Africa from 24 to 25 February 2016 in Addis Ababa, Ethiopia under the theme ‘‘towards
universal immunization coverage as a cornerstone for health and development in Africa”. The conference
brought together African leaders – including health and finance ministers, and parliamentarians thus cre-
ating a powerful platform for governments to demonstrate their commitment to advancing universal
access to immunization on the continent in line with the Global Vaccine Action Plan. The event also
brought together advocates, technical experts, policymakers, partner agencies, donors and journalists
to examine how best to drive forward immunization across Africa, ensuring every child has access to
the vaccines they need. Key points highlighted throughout conference were: universal access to immu-
nization is at the forefront of enabling Africa to reach its full potential – by improving health, driving eco-
nomic growth and empowering future generations; it is one of the most cost-effective solutions in global
health, with clear benefits for health and development; and immunization brings economic benefits too,
reducing health care costs and increasing productivity. At the close of the conference, 46 African coun-
tries signed a historic ministerial declaration on ‘‘Universal Access to Immunization as a Cornerstone for
Health and Development in Africa” signaling fierce determination among African leaders to secure the
health and prosperity of their societies through immunization.
 2016 World Health Organization Regional Office for Africa. Published by Elsevier Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Immunization against vaccine preventable diseases (VPDs) has
contributed to saving millions of lives. It was the fundamental
strategy for the eradication of smallpox. Polio is now on the brink
of eradication due to the efficacy of vaccines. More children than
ever before now live healthy lives free of VPDs, because of
immunization.
Beyond the public health benefits, immunization against VPDs
has other social and development benefits. It has been demon-
strated that every dollar invested in vaccines during the decade
of 2011–2020 would result in an estimated return of 16 times
the costs, taking into account treatment costs and productivity
losses [1]. When considering broader economic and social benefits
the return on investment for immunization was 44 times the vac-
cination costs [2].To optimize these benefits of immunization the World Health
Assembly (WHA) endorsed the Global Vaccine Action Plan (GVAP),
a framework to achieve the vision of expanding access to vaccines
and immunization to all by 2020. GVAP targets include 90%
national coverage for 3rd doses of Diphtheria–Tetanus–Pertussis
(DTP3) containing vaccines [3]. Meeting the targets requires
achieving universal coverage with immunization services. Member
States committed to strengthening national immunization systems
to ensure equitable access to vaccines for all people by 2020.
Progress has been made toward realizing the targets. Coverage
with the 3rd dose of diphtheria–Tetanus–Pertussis (DTP3), com-
monly used to measure the strength and reach of routine immu-
nization programmes, increased from 57% in 2000 to 80% in 2014
in Africa. Improvements in immunization coverage have resulted
in fewer VPDs among children in Africa [4–10]. As a result of
immunization efforts, between 2000 and 2014, estimated measles
deaths globally have declined by 69%, while the number of
reported measles cases have declined by 69%. The largest decline
in estimated measles deaths is in the African Region where measles
deaths declined by 86% to 48,000 between the years 2000 and 2014
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success. The GVAP target of at least 90 low- and middle-income
countries introducing one or more new or underutilized vaccines
is on track [3]. Introducing new vaccines can help improve health
systems. Vaccines provide benefits to families, communities and
countries in the form of improved health outcomes and economic
growth [12].
Despite these achievements, some critical diseases, including
measles and neonatal tetanus, which have been eliminated or
nearly eliminated in most regions of the world, remain endemic
in Africa [5]. Worse still, the pace of improvements in routine
immunization coverage, between 2000 and 2014, has in recent
years decelerated. Fewer than half of African countries have met
the GVAP target on DTP3 coverage. Government funding for immu-
nization in African countries has increased in recent years, comple-
mented by donor funds. However, in many countries across Africa,
additional funding is required to ensure equitable and universal
access to vaccine and immunization services in all the countries.
There is an urgent need for more reliable national ownership of
immunization programmes with commitment for guaranteed
funding of all aspects of immunization in the Region.
Responding to this need, the WHO Africa and the Eastern
Mediterranean Regional Offices in conjunction with the African
Union Commission convoked a ministerial conference on immu-
nization in Africa from 24 to 25 February 2016 in Addis Ababa,
Ethiopia. The conference pulled together over 800 participates,
including Ministers for Health, Local Government and Finance of
the African countries. Others included national immunization pro-
gram managers, past and present heads of governments in Africa,
parliamentarians, religious/traditional leaders, civil society organi-
zations, the private sector, technical experts and immunization
partners across Africa and beyond. It provided a platform for Afri-
can policymakers and to advocates to discuss strategies for tackling
the challenges facing vaccine efforts, foster country ownership for
sustainable financing for immunization, and advocate for greater
engagement with all stakeholders to ensure sustainable demand
for immunization. This paper summarizes the proceedings of the
conference and proposed steps to tackle the challenges to achiev-
ing universal and equitable access to effective vaccines, thus keep-
ing with the ethical and moral obligation to guarantee the life of
the future generation through access to life-saving vaccine in
Africa [13]. The programme included panel sessions and side
events, covering the different aspects of immunization in the
continent.2. Toward high and equitable immunization coverage
Improving coverage and equity in immunization programmes is
a critical element of ensuring immunization for all, in line with the
commitments made in the GVAP. Coverage with DTP3 containing
vaccines in Africa stood at 80.9% in 2014 [14]. About forty-three
percent (42.6%) of the African countries had coverage rates of
P90% in 2014. However, approximately 23% or 7.4 million infants,
within the WHO African Region, were not reached with the 3rd
dose of DTP vaccines in 2014. A third of these children were in
Ethiopia, Kenya, DR Congo, South Sudan, Nigeria and Guinea [12].
Djibouti and Somalia in the WHO Eastern Mediterranean Region
had coverage rates of 78% and 42% respectively. Discussions were
held around this issue, examining ways partners can identify
underserved populations, develop effective plans for improving
coverage, and strengthen collaboration among sectors. Participants
offered various perspectives on the challenge of reaching hard to
reach populations and improving equity and access to immuniza-
tion, shared lessons and experiences, as well as what is most
needed from various sector and partners to reach every child withimmunization services. Speakers in this session also discussed par-
ticular challenges of ensuring increased coverage with new and
under-utilized vaccines, or ensuring resources are focused on
specific low coverage geographic areas or target groups.
Some of the major themes that emerged from the panel discus-
sion include strengthening immunization systems as an entry
point for strengthening primary health care, and health systems;
increasing number of vaccines, as well as the scope and costs for
vaccination and the high economic returns of immunization.
Others included the fragility of service delivery systems in conflict
and disaster situations and need for better vaccine pricing for non
GAVI eligible countries and countries transitioning into middle
class. Participants highlighted the fact that countries now have
new and powerful vaccines to prevent various types of diseases,
and avert many deaths. Countries in Africa have collectively
reached the highest immunization rate with DTP3 at 80.9% cover-
age in 2014. However, this still leaves behind one out of five chil-
dren. They gave the examples of interruption of polio virus
circulation and the successes in preventing meningitis A epidemics
in Africa, and stressed on the remaining inequalities at subnational
level in some of the big countries. Given the plateauing measles
vaccination coverage in Africa in the last 5 years, and the outbreaks
in some countries, it is important to work toward getting better
data to better target populations and achieve high immunity cov-
erage at sub-national level. A call was made for the development
of tailored strategies to reach low coverage areas and underserved
populations will be critical, and will require using data driven
approaches. In addition, the critical lessons from the polio eradica-
tion initiative should be applied, when it comes to engaging the
community, running functional supply chains and cold chain sys-
tems, among others. Also emphasized was the role of the private
sector, alongside the public sector, in making vaccines available.3. The role of communities in coverage and demand
Here, the point was made that civil society and community-
level work is critical to advancing health. This is particularly
important for increasing demand for and uptake of available ser-
vices through social and behavioral change interventions, ensuring
government transparency and accountability, and supporting
resource mobilization. Other areas include influencing national
health policies and supporting the monitoring and evaluation of
effective programs. Effective engagement of communities is essen-
tial to ensuring continued progress toward universal access to
immunization [15].
Participants thus examined how partners can identify under-
served populations, develop effective plans for improving cover-
age, and strengthen collaboration among sectors. Discussions
focused on the roles that religious and traditional leaders/authori-
ties, youth and community based civil society organizations (CSO)
and other groups and stakeholders could play in promoting immu-
nization in the communities. It was noted, for instance, that tradi-
tional and religious leaders were fundamental to engaging
communities for change in Africa, as demonstrated in Nigeria
where their involvement strongly and positively influenced the
uptake of polio vaccines in Northern Nigeria. Another example of
community engagement for health in Africa was the experience
of Ethiopia with extension health workers for the delivery of essen-
tial health services at the community level, which has become a
remarkable success for health in Ethiopia. The cost of launching
the extension health worker scheme was heavy initially because
of the added workforce into the health expenditure. However,
the Honourable Minister stated that ‘‘the good thing now is that
cost of health care has gone down in Ethiopia.
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cess factor for all health interventions. Participants emphasized
the need to build community trust and ownership. They called
for increased awareness to address community barriers that could
hinder the access to services to be able to reach the 5th child and
increase demand.
Some of the key challenges mentioned included the communi-
ties’ lack of information on immunization, poor geographical
access because of the lack of infrastructure and difficult terrains,
supply chain problems, and programming around health facilities.
Participants remarked that CSOs have the capacity and proximity
to give accurate information to the communities and to empower
the communities to understand their rights, which will see the
communities initiating their own effort. A call was made for part-
ners to begin to see CSOs as equal partners. The youth was identi-
fied as an important part of the community, and with the potential
to mobilize the community towards better health, including a
stronger demand and better uptake of immunization services.4. Harnessing polio’s legacy to support other public health
interventions
Africa achieved a major global health milestone in February
2016 when it reached 18 months with no indigenous case of wild
poliovirus (WPV) detected on the continent. Even as the polio erad-
ication initiative redoubles its efforts to achieve regional certifica-
tion in 2017, Africa needs to plan early for the eventual ramp down
of Global Polio Eradication Initiative (GPEI) support. GPEI support
for polio-funded resources will gradually reduce over the next
three years, as regional and global certification of polio eradication
draws closer. In preparation for this ramp down, national govern-
ments, donors, implementing partners and civil society must work
together to plan for a successful transition.
Participants noted that the polio eradication initiative has built
an extensive infrastructure with broad benefits for health and
development in Africa. This infrastructure includes: a large trained
workforce, including a network of thousands of national technical
staff, over 4000 partner-supported technical personnel, tens of
thousands of engaged religious leaders, polio survivors and social
mobilizers, and hundreds of thousands of trained vaccinators at
the local level; a system for standardized, real-time disease surveil-
lance with 16 dedicated laboratories and 51 environmental sam-
pling sites in 7 countries in the African Region with similar
statistics in the Eastern Mediterranean Region; a stronger vaccine
supply chain and detailed mapping of nomadic and hard-to-
reach communities previously unreached by other health services;
and robust processes for using data to hold individuals and sys-
tems accountable for results based on strong operational data col-
lection, real-time monitoring, and transparent reporting
mechanisms. Participants also emphasized the importance of
countries taking steps now to document the lessons learned from
polio eradication, and taking a coordinated approach to planning
the transition of polio’s infrastructure into ongoing health pro-
grams. They took the opportunity of this session to address what
those working on other health priorities hope to gain, or are
already gaining, from the polio programme’s assets and expertise.
They called on African countries to take advantage of the full
potential of the polio programme, and build a lasting legacy that
will benefit children for generations.
Some of the major issues raised in the panel discussion focused
on polio legacy and mainstreaming essential polio functions into
ongoing public service programs; using polio infrastructure to
strengthen other public health priorities; applying lessons from
the fight against polio to other critical health challenges and the
question of what other health priorities would want to take fromthe polio legacy. The delegates were sensitized on the polio transi-
tion planning.5. Ensuring sustainable resources for immunization in an
evolving landscape for health
Ensuring sustainable resources for immunization was one of the
most important topics discussed at the Ministerial Conference on
Immunization in Africa. Estimates put the cost of fully vaccinating
a child at US$25–$45 [1,16,17], but even this figure does not take
into account non-vaccine costs of delivering the service, training,
supervision, monitoring and tracking outbreaks, addressing popu-
lation demand for services or managing programmes. Several stud-
ies suggest that non-vaccine costs represent nearly half of the total
cost per child.
To ensure every child receives the required vaccines, govern-
ments need to carefully plan and adequately budget for both vac-
cines and the delivery costs of immunization programmes. While
governments have made significant strides to increase funding
for immunization programmes over the last five years, further
commitment is needed to achieve full financing and national own-
ership of immunization programmes.
The discussion highlighted the need to ensure sustainable
resources for immunization across Africa and how immunization
financing is shifting in recent years. Participants shared experi-
ences and lessons learned from working to solve immunization
financing challenges, and offered suggestions on how to achieve
country ownership of immunization programs in Africa. Opportu-
nities for expanding domestic immunization financing, in view of
rising costs of new vaccines and technologies, were also
highlighted.
It was noted that between 2016 and 2020, Africa will require US
$17 billion for vaccines and vaccination service delivery. Cost pro-
jections indicate that Governments are expected to provide US$6
billion while the donor community is expected to raise another
US$6 billion, leaving a funding gap of about US$5 billion. On the
other hand, it was stated that African countries are expected to
derive the benefits of vaccination equivalent to about US$224 bil-
lion in direct returns and savings from vaccine preventable dis-
eases. It was also argued that countries need to see investment
in immunization as a moral issue to assure that the young popula-
tion is protected for the future, in order to drive the economies.
Consequently, sustainable financing for immunization will come
about through the realization that investments in immunization
payoff, and make economic and moral sense. The Ugandan experi-
ence in working toward sustainable financing of immunization
was shared. Uganda now spends US$11 per surviving infant for
immunization, with increases in DPT3 coverage. The Immunization
Act was passed in 2015 and provides the legal framework for fund-
ing. With the high competition for donor resources for many devel-
opment and emergency relief efforts, countries were called upon to
seek innovative funding for immunization, is today a best buy in
health.
Though mindful of the fact that countries have multiple priori-
ties for public sector development funding, participants stressed
that the cost of vaccines is often no more than 0.5% of the total
national budget, and less than 2% of the health budget for most
developing countries, which should not be a huge challenge for pri-
oritizing in budgeting and funds disbursement. Countries were
encouraged to increase their domestic financing for immunization
and improve on the situation where currently 14 countries in
Africa are currently not buying their vaccines and that 9 countries
do not meet co-funding obligations with the Gavi Alliance [18].
There were also calls for the generation, tracking and sharing of
immunization financing and expenditure data in order to track
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tainable financing for immunization.6. Immunization delivery and data as a pillar of universal health
coverage
Building robust national immunization programmes will be
central to ensuring children’s health and ensuring the vision of uni-
versal health coverage. Central to this effort is an increased under-
standing of national vaccine coverage, which is critically important
for monitoring the performance of immunization programmes,
identifying areas within immunization systems that require
improvements, and preparing for the introduction of new vaccines.
Strengthening immunization data quality and coverage estimates,
and using the data for improving immunization program perfor-
mance, are critical steps toward improving coverage in Africa.
Participants recognized the role of Ministers, the WHO and pri-
vate sector in improving access to immunization through strong
delivery systems and better data collection, and explored the deliv-
ery challenges and opportunities around reaching every child in
Africa with the vaccines they need by 2020. Within this context,
participants discussed how investments in novel delivery
approaches and new data and analytics software are driving local
and national progress toward reaching immunization goals. Specif-
ically, the long-term goals for strengthening immunization sys-
tems and data collection, their strategies to drive African-led
R&D and their visions for African-led solutions as pillars of univer-
sal health coverage were discussed exhaustively.
The invaluable role of community involvement, and better
inter-sectoral coordination was highlighted. Countries emerging
from conflict were encouraged to focus on building health systems,
maintaining a motivated, well trained health work force and use
the available technology to understand and address local needs.
Some of the common themes from this panel discussion were
the increasing role of the private sector in developing countries
in complementing the public health system. The panel also high-
lighted the gains in integrating service delivery approaches. Fur-
thermore, the role of technology to facilitate the data capture
and management, and the immense challenges of providing immu-
nization and other health service delivery in conflict and emer-
gency contexts were extensively discussed.
There was a call for countries and partners to invest in more
robust, transparent and reliable data for monitoring and account-
ability. Furthermore, countries were called upon to ensure that
all contacts with health services are used to provide integrated ser-
vices to families and finally, governments were encouraged to
acknowledge the crucial role of the private sector in service deliv-
ery, training, and logistics, among others.7. Enhancing partnerships to strengthen capacity for
immunization and health
Strengthening existing partnerships and creating new ones will
be strategic to improving access to immunization in Africa [19].
Examples of such partnerships include cooperation between gov-
ernments, investment institutions, charitable foundations and
regional partnerships. Immunization is a complex health service,
requiring many pieces of functioning infrastructure, such as financ-
ing sources, supply chains and human resources. Understanding
how partnerships function and improve can help us support
immunization while also advancing mutual interests between
partners.
Finding new approaches to utilizing partnerships has to come as
a need from all levels of government and beyond. Policy makers
have to open the door for collaboration, and partners have to createinnovative solutions that can expand access to immunization in
new ways. Cooperation at the country, regional and global levels
can advance our common interest in building a healthier continent.
The MenAfriVac meningitis vaccine success story is a proof of the
potential of public and private partnerships to improve access to
immunization.
Participants examined how African and global institutions can
cooperate to increase access to immunization and other health ser-
vices and drew on specific experiences to develop insights applica-
ble to a range of countries. It was noted that the immunization
community and African governments need to translate the com-
mitments made at the Ministerial conference and other meetings
into concrete actions, and be held accountable to these commit-
ments. It was recalled that only 6 countries met the Abuja declara-
tion targets 15 years on, and what roles regional partnerships can
play to push for these [20]. Discussions focused on the need to base
partnership on the needs of the countries and communities; coun-
try self-reliance in mobilizing resources for immunization and the
role of religious institutions and leaders, as well as civil societies in
promoting immunization.
After an elaborate discussion, which saw representatives of dif-
ferent development agencies and immunization partners as well as
country delegates expressing their appreciation for strong partner-
ship for immunization in Africa, some key issues emerged to
inform the agenda for moving forward. These included the call
on countries to decrease their dependency on donor funding, and
look at different models to mobilize local resources for immuniza-
tion. Countries were also encouraged to ensure accountability to
the commitments they have entered into and to the global and
regional immunization goals. Other issues that emerged include
the need for countries to work toward pooling their experiences
and resources toward developing their infrastructure and their
capacity for vaccine manufacturing; to build strong, sustainable,
multi-sectorial and multi-level partnerships based on the needs
of the countries and communities. Furthermore, countries and
partners were called upon to work toward generating and using
subnational and district level data and ensure that religious insti-
tutions and leaders, the private sector, the citizenry, community
based organizations (CBOs) are part of a strong partnership for
the mobilization of resources, as well as advocacy and social
change for immunization and for public health in general8. Consensus and ministerial declarations
The conference reviewed the situation on immunization and
vaccines in the African continent and noted that the principal chal-
lenge is how to ensure universal and equitable access by all people
irrespective of their social class or geographic locations. The theme
of this first ministerial conference on immunization in Africa –
‘‘Towards universal immunization coverage as cornerstone for
health and development in Africa”, was reflected in the agenda
which featured panel discussions to interrogate the key issues
and challenges as well as side events, in which community/reli-
gious leaders, parliamentarians and civil society organizations
pledged their support and commitment to a vibrant and sustain-
able immunization programme in the continent.
Participants were unanimous in their resolution that ‘‘this is the
time for Africa to rise. In one voice that argued ‘‘that African cannot
rise if the life of the children and future generation is not guaran-
teed. One way to guarantee their lives is to invest in life saving vac-
cines. Great progress has been made but much more needs to be
done”.
Participants recognized milestone achievements in immuniza-
tion in Africa, some of which included the achievement of elimina-
tion of meningitis A epidemics in most of the highly affected
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improvements in immunization coverage and reductions in child-
hood death and disease. They also recognized the need for greater
and sustained demonstration of country ownership and partner-
ship across key African stakeholder groups, and highlighted the
challenges of vaccine affordability and the need to expand country
health financing.
The conference concluded with delegates endorsing the Minis-
terial declaration on ‘‘Universal Access to Immunization as a Corner-
stone for Health and Development in Africa”. This declaration
committed African leaders to strive toward closing the immuniza-
tion gap by financing immunization, reducing delivery barriers,
ensuing polio transition plans are in place and improving health
systems. By this declaration, African leaders unequivocally
asserted that immunization saves lives, strengthens economies,
and is essential to achieving a healthy future for all. Civil society
organizations, religious leaders and parliamentarians also issued
declarations at the end of the conference in support of
immunization.
The Minister committed themselves, on behalf of their respec-
tive countries, to:
 Keeping universal access to immunization at the forefront of
our efforts to reduce child mortality, morbidity and disability,
and in doing so help our countries achieve their long-term
health, economic and development goals;
 Increasing and sustaining our domestic investments and fund-
ing allocations, including innovative financing mechanisms, to
meet the cost of traditional vaccines, fulfil our new vaccine
financing requirements, and providing financial support for
the operational implementation of immunization activities by
EPI programs;
 Addressing the persistent barriers in our vaccine and healthcare
delivery systems, especially in the poorest, vulnerable and most
marginalized communities, including the strengthening of data
collection, reporting and use at all levels as well as building
effective and efficient supply chains and integrated procure-
ment systems;
 Increasing the effectiveness and efficiency, as well as changing
the approaches as needed, of our immunization delivery sys-
tems as an integrated part of strong and sustainable primary
health care systems;
 Attaining and maintaining high quality surveillance for targeted
vaccine preventable diseases.
 Monitoring progress toward achieving the goals of the global
and regional immunization plans
 Ensuring polio legacy transition plans are in place by end-2016
that will allow future health programs to benefit from the
knowledge and expertise the polio program has generated
through the eradication initiative;
 Developing a capacitated African research sector to enhance
immunization implementation and uptake;
 Building broad political will, working with communities, civil
society organizations, traditional and religious leaders, health
professional associations and parliamentarians, for the right of
every child and every community to have universal access to
life-saving vaccines, and by extension the best possible chance
for a healthy future;
 Promoting and investing in regional capacity for the develop-
ment and production of vaccines in line with the African Union
Pharmaceutical Manufacturing Plan including the strengthen-
ing of national regulatory authorities.
The Ministers thanked his Excellency Hailemariam Desalegn,
Prime Minister of the Federal Democratic Republic of Ethiopia,
and host country for this Ministerial Conference on Immunizationin Africa, for agreeing to champion the Ministerial declaration and
further requested him to present it to the African Heads of States at
the 26th Summit of the African Union, to be held in June 2016.
Side-events offered an opportunity for constituencies to have
in-depth conversations on specialized topics:
 The Meningitis Vaccine Project Closure Conference: Ending
and New Beginnings: The Meningitis Vaccine Project (MVP),
a partnership between PATH and the World Health Organiza-
tion (WHO) was launched in June 2001 and formally ended in
December 2014. This satellite meeting celebrated successes
from the program; shared results, experiences and lessons
learned; and planned the next steps to ensure continued sup-
port for the remaining vaccination campaigns and a smooth
transition into routine immunization programs.
 Building next-generation immunization supply chains to
close the immunization gap: Co-hosted by WHO, UNICEF,
PATH, John Snow Inc, Gavi, the Vaccine Alliance, and the Bill &
Melinda Gates Foundation, this event highlighted the work that
several African countries are doing today to strengthen their
supply chains and improve immunization coverage and equity.
 Civil Society: Promoting Equity & Holding Governments
Accountable: Organized by several partners, this event pro-
vided an opportunity for CSOs to discuss their role in holding
governments accountable to improve vaccine access and cover-
age in Africa in line with the Global Vaccine Action Plan.
Through presentations and breakout sessions, participants
reviewed current and best practices in community-level immu-
nization advocacy and outreach work and identified ways CSOs
can best work together following the conference. An open ses-
sion of the meeting provided a forum for other stakeholders
to join the discussion about the role civil society in immuniza-
tion. In recognition of the vital role of immunization to health
and economic development of Africa the CSO groups pledged
to take action on bridging the gap on immunization, utilizing
their unique capacities as CSOs to forge connections between
communities, health services and the government responsible
to the communities.
 Side Forum of Eminent African Traditional and Religious
Leaders and Scholars: International Interfaith Peace Corps
(IIPC) convened 30–40 eminent Muslim and Christian religious
scholars and traditional leaders at this closed side forum. The
forum provided a space for these leaders to identify strategies
to advance and support immunization within their communi-
ties. The traditional and religious leaders reaffirmed their sup-
port to the Dakar Declaration in relation to vaccinations in
Africa.
 In recognition of their pivotal role of budgeting, oversight ad
formulation f legislations, the parliamentarians committed to
support enactment of legislations to ensure sustainable financ-
ing of immunization programs.References
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